Early Access Care fills the gap by developing effective and integrated solutions customized to clients' Expanded Access or Compassionate Use needs; the company specializes in Expanded Access (USA) and Compassionate Use (outside of USA). "By collaborating with biopharmaceutical firms, we intend to make 'Access More Accessible' for patients and their physicians," states John Cropp, CEO, and SVP of Technology of Early Access Care. The company provides comprehensive services to manage expanded access program requests globally, freeing up resources for biopharmaceutical companies to concentrate on the development of new drugs.
Early Access Care is renowned for its wide range of services, such as designing Expanded Access programs and policies, protocol development, end-to-end operational management of global programs, provisioning Early Access Care's eTool, and managing physician requests across the world. The company utilizes the Early Access SystemTM – a proprietary web-based 'all-in-one' software for managing Expanded Access and Compassionate Use requests. The Early Access SystemTM software is an end-to-end eTool customized for each investigational medicine, enabling comprehensive management of Early Access programs across the globe.
With such unmatched core competencies, Early Access Care has ignited several success stories since its inception. In one instance, the company assisted a baby suffering from an ultra-rare neurologic disease in Europe. The company received an urgent request from a pharmaceutical company asking for assistance navigating the emergency early access options to enable expedited treatment for the baby. Within an hour, the team at Early Access Care was providing detailed information on local country regulations, process, and guidance on next steps necessary to deliver the investigational drug to the patient. By leveraging the Early Access SystemTM and the team’s expertise, the pharmaceutical company was able to save the baby's life.
By collaborating with biopharmaceutical firms, we intend to make 'Access More Accessible' for patients and their physicians
From an organizational standpoint, Cropp envisions a future where Early Access Care is a key driver in helping pharma companies, physicians, and patients manage Expanded Access. "We will always continue stoking the fire of innovation to expand the horizons of our services and help our clients guarantee quality and rapid delivery of life saving treatments," concludes Cropp.